|
Recent Publications:
Bini EJ, Brau N, Currie S, Shen H, Anand BS, Hu K-Q, Jeffers L, Ho SB, Johnson D, Schmidt W, King P, Cheung R, Morgan TR, Awad J, Pedrosa M,
Chang K-M, Aytaman A, Simon F, Hagedorn C, Moseley R, Ahmad J, Mendenhall C,
Waters B, Strader D, Sasaki AW, Rossi S, Wright TL. Prospective Multicenter Study
of Eligibility for Antiviral Therapy among 4,084 U.S. Veterans with Chronic Hepatitis
C Infection. Am J Gastroenterol 2005: 100:1772
Cheung RC, Currie S, Shen H, Ho SB, Bini EJ, Anand BS, Brau N, Wright TL, for the VA HCV001 Study Group. Chronic Hepatitis C in Latinos: Natural History, Treatment
Eligibility, Acceptance, and Outcomes. Am J Gastroenterol 2005; 100:2186-93.
N. Brau, E. J. Bini, S. Currie, H. Shen, W. N. Schmidt, P. D. King,
S. B. Ho, R. C. Cheung, K.-Q. Hu, B. S. Anand, F. R. Simon, A. Aytaman, D. P.
Johnson, J. A. Awad, J. Ahmad, C. L. Mendenhall, M. C. Pedrosa, R. H. Moseley,
C. H. Hagedorn, B. Waters, K.-M.
Chang, T. R. Morgan, S. J. Rossi, L. J. Jeffers,
T. L. Wright, The VA-HCV-001
Study Group. Black patients with chronic hepatitis C have a lower sustained viral
response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent
dose reductions of interferon and ribavirin. Journal of Viral Hepatitis,
2006, 13, 242–249.
Bini
EJ, Currie SL, Shen H, Brau N, Schmidt W, Anand BS, Chung R, Wright TL, for the VA-HCV 001 Study Group. National Multicenter
study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol 2006; 40:732-9.
|